ST-246 600 mg

Drug identity checked against registry records

Also recorded as Tecovirimat

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246NCT00907803SIGA TechnologiesPhase 2Completed2010-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.